While most people who have COVID-19 recover completely within a few weeks, some continue to experience symptoms weeks after their initial recovery. This condition is often called Long COVID. Common signs and symptoms of Long COVID include fatigue, shortness of breath or difficulty breathing, cough, joint pain, chest pain, and even organ damage, according to the Mayo Clinic. But we don’t know everything about the long-term health effects of COVID-19 infection. You can help researchers learn more about Long COVID through research studies, such as RECOVER, a National Institute of Health (NIH) study to better prevent, test, and treat Long COVID-19 in the future. Find a recover testing site near you!
RECOVER Research Study
The NIH launched RECOVER to learn why some people ...
Ever heard of donating biospecimens for research? When a person donates biospecimens—blood, fluid, or tissue samples—it gives researchers the opportunity to better understand, treat, and prevent medical conditions from cancer to Alzheimer's. Biospecimens are especially needed from Latinos, who suffer health disparities. Let’s use #SaludTues on Tuesday, July 5, 2022, to tweet about the need for biospecimen donations, how researchers use the donations, and how you can donate to improve health for all people! WHAT: #SaludTues: What Is Biospecimen Donation and Should You Donate?
TIME/DATE: 1-2 p.m. EST (Noon-1 p.m. CST), Tuesday, July 5, 2022
WHERE: On Twitter with hashtag #SaludTues
HOST: @SaludAmerica
CO-HOSTS: Melissa Simon, Health Equity Researcher, ...
Substance abuse in the US is a public health problem that affects many people, including Latinos. Yet, Latinos are less likely than their White peers to get treatment they need. There is a new investigational treatment for substance abuse —the use of Repetitive Transcranial Magnetic Stimulation (rTMS), a non-invasive procedure that uses magnetic pulses to temporarily stimulate areas of the brain. Fortunately, you can make a difference by representing Latinos in the Stimulus Research Study, a clinical trial at UT Health San Antonio and other sites that will help researchers learn if the use of rTMS can help people reduce or stop their cocaine or methamphetamine use. “The rTMS clinical trial and others like it hope to develop and apply new treatments that work for Latinos ...
“The good news is, we can’t kill you trying to save you. You showed up fit to fight.” Still in shock of recent events, Loriana Hernandez-Aldama tried to process the words of world-renowned oncologist Dr. Mark Levis. In such a short period of time in January 2014, her life had completely changed. Just a few days earlier, Loriana, a married mother and TV news anchor with a successful career in Austin and Dallas, Texas, was excitedly working with her fertility doctor to have another baby. But a precautionary blood test before a traditional embryo transfer revealed a disheartening diagnosis of AML Leukemia, an aggressive blood cancer. At the advice of her doctor and healthcare connections, she kissed her then 2-year-old son, Gabriel, goodbye, and boarded a plane to Johns ...
Latinos represent less than 10% of volunteers in cancer clinical trials. The lack of Latinos in clinical trials makes it harder for researchers to find treatments tailored for this group — which makes up 18.5% of the U.S. population and a diversity of heritages. This is why Drs. Amelie G. Ramirez and Patricia Chalela of UT Health San Antonio identified barriers and strategies to boost Latino representation in clinical trials in a new commentary in JCO Oncology Practice. It will take more than simply raising awareness of clinical trials to everyone. "To achieve equitable participation of Latinos and other underrepresented groups in clinical research, we need comprehensive approaches that address social and contextual barriers to participation," said Ramirez, leader of the ...
Los latinos representan menos del 10% de los voluntarios en los estudios clínicos de cáncer (enlace en inglés). La falta de latinos en los estudios clínicos hace que sea más difícil para los investigadores encontrar tratamientos desarrollados específicamente para este grupo – que representa el 18.5% de la población de los Estados Unidos y una diversidad de culturas. Las doctoras Amelie G. Ramírez y Patricia Chalela de UT Health San Antonio identificaron barreras y estrategias para promover la representación latina en los estudios clínicos en un nuevo comentario (enlace en inglés) publicado en JCO Oncology Practice. Se necesitará más que simplemente aumentar el conocimiento sobre los estudios clínicos. "Para lograr la participación equitativa de los latinos y ...
June is Alzheimer’s & Brain Awareness Month! This is a good time to reflect on the many challenges and inequities facing people of color in the United States when it comes to Alzheimer’s Disease, dementia, and brain health. Sadly, U.S. Latinos are 1.5 times more likely to develop Alzheimer’s disease than whites. Latino caregivers experience high levels of stress when supporting their family members with the disease. Let’s use #SaludTues on Tuesday, June 7, 2022, to tweet about the latest data, strategies, and programs to prevent and reduce Alzheimer’s disease and promote better brain health among Latinos and all people! WHAT: #SaludTues: How to Address Alzheimer’s in the Latino Community
TIME/DATE: 1-2 p.m. EST (Noon-1 p.m. CST), Tuesday, June 7, 2022
...
Doctors often have implicit, subconscious preferences for white patients over those of color, studies show. This is implicit bias. These biases — stereotypes that affect our understanding and decisions about others beyond our conscious control — lead to discrimination and health disparities. To address this issue, you’re invited to join us for "Overcoming Implicit Bias in the Doctor’s Office and Research Studies," at 2 p.m. CT on April 25, 2022. This is the third webinar of a new series, “Let’s Address Health Equity Together.” This Zoom webinar will feature guest speakers to help health care professionals understand implicit bias, “rewire” it toward compassion for patients and research participants of color and engage local leaders in implementing implicit bias ...
March is Colorectal Cancer Awareness Month. This cancer can affect anyone, but older Latinos may be particularly at risk. Know the facts about colorectal cancer, tips for screening and preventions, and how we can help researchers studying cancer.
What Should I Know About Colorectal Cancer?
Colorectal cancer is the disease of the colon and/or rectum. “Most cases of colorectal cancer occur in people ages 45 and older, but the disease is increasingly affecting younger people. Each year, about 150,000 Americans are diagnosed with this disease and more than 50,000 die,” according to the Colorectal Cancer Alliance. Many people in the early stages of colorectal cancer do not experience symptoms. However, symptoms might develop later on in the disease. Mayo Clinic lists ...
